These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 18429637)

  • 1. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.
    Ahn K; McKinney MK; Cravatt BF
    Chem Rev; 2008 May; 108(5):1687-707. PubMed ID: 18429637
    [No Abstract]   [Full Text] [Related]  

  • 2. The complications of promiscuity: endocannabinoid action and metabolism.
    Alexander SP; Kendall DA
    Br J Pharmacol; 2007 Nov; 152(5):602-23. PubMed ID: 17876303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids: getting the message across.
    Alger BE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8512-3. PubMed ID: 15173576
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipidomic analysis of endocannabinoid metabolism in biological samples.
    Astarita G; Piomelli D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2755-67. PubMed ID: 19171504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting brain glucose metabolism to fight neurodegeneration?
    de Ceballos ML; Köfalvi A
    Oncotarget; 2017 Feb; 8(9):14273-14274. PubMed ID: 28184023
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of a peripheral receptor for cannabinoids.
    Munro S; Thomas KL; Abu-Shaar M
    Nature; 1993 Sep; 365(6441):61-5. PubMed ID: 7689702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.
    Cravatt BF; Giang DK; Mayfield SP; Boger DL; Lerner RA; Gilula NB
    Nature; 1996 Nov; 384(6604):83-7. PubMed ID: 8900284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme inhibitor discovery by activity-based protein profiling.
    Niphakis MJ; Cravatt BF
    Annu Rev Biochem; 2014; 83():341-77. PubMed ID: 24905785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
    Tripathi RKP
    Eur J Med Chem; 2020 Feb; 188():111953. PubMed ID: 31945644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System and its Modulation by Phytocannabinoids.
    Di Marzo V; Piscitelli F
    Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predator odor stress reactivity, alcohol drinking and the endocannabinoid system.
    Ornelas LC; Besheer J
    Neurobiol Stress; 2024 May; 30():100634. PubMed ID: 38623398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome.
    Ellermann M
    Adv Drug Alcohol Res; 2023; 3():11359. PubMed ID: 38389811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of [
    Nag S; Jia K; Arakawa R; Datta P; Scott D; Shaffer C; Moein MM; Hutchison M; Kaliszczak M; Halldin C
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of Endothelial-Derived 2-AG Reduces Blood-Endothelial Barrier Integrity via Alteration of VE-Cadherin and the Phospho-Proteome.
    Levine AA; Liktor-Busa E; Balasubramanian S; Palomino SM; Burtman AM; Couture SA; Lipinski AA; Langlais PR; Largent-Milnes TM
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls.
    Spohrs J; Kühnle V; Mikusky D; Sanhüter N; Macchia A; Nickel S; Abler B
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid and psychological responses to acute resistance exercise in trained and untrained adults.
    Sirotiak Z; Gallagher BT; Smith-Hernandez CA; Showman LJ; Hillard CJ; Brellenthin AG
    PLoS One; 2023; 18(12):e0291845. PubMed ID: 38039265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.